Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity

GY Ku, A Chopra, G de Lima Lopes Jr - Lung Cancer, 2010 - Elsevier
INTRODUCTION: Hepatotoxicity secondary to gefitinib, an oral tyrosine kinase inhibitor (TKI)
against the epidermal growth factor receptor (EGFR), is under-appreciated, even though it …
被引用次数：29 相关文章

Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity

GY Ku, A Chopra, G de Lima Lopes… - Lung cancer …, 2010 - scholarship.miami.edu
Introduction: Hepatotoxicity secondary to gefitinib, an oral tyrosine kinase inhibitor (TKI)
against the epidermal growth factor receptor (EGFR), is under-appreciated, even though it …

Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity.

GY Ku, A Chopra, LG L Jr - Lung Cancer (Amsterdam, Netherlands), 2010 - europepmc.org
Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced
hepatotoxicity. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

[引用][C] Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity

GY Ku, A Chopra, G de Lima Lopes - Lung Cancer, 2010 - cir.nii.ac.jp
Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced
hepatotoxicity | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity

GY Ku, A Chopra… - Lung cancer …, 2010 - pubmed.ncbi.nlm.nih.gov
Introduction Hepatotoxicity secondary to gefitinib, an oral tyrosine kinase inhibitor (TKI)
against the epidermal growth factor receptor (EGFR), is under-appreciated, even though it …

Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity

GY Ku, A Chopra, G de Lima Lopes - Lung Cancer, 2010 - pure.johnshopkins.edu
Introduction: Hepatotoxicity secondary to gefitinib, an oral tyrosine kinase inhibitor (TKI)
against the epidermal growth factor receptor (EGFR), is under-appreciated, even though it …

Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity

GY Ku, A Chopra, G de Lima Lopes - Lung Cancer, 2010 - infona.pl
Hepatotoxicity secondary to gefitinib, an oral tyrosine kinase inhibitor (TKI) against the
epidermal growth factor receptor (EGFR), is under-appreciated, even though it has a …

Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity

GY Ku, A Chopra, G de Lima Lopes - Lung Cancer, 2010 - lungcancerjournal.info
Introduction Hepatotoxicity secondary to gefitinib, an oral tyrosine kinase inhibitor (TKI)
against the epidermal growth factor receptor (EGFR), is under-appreciated, even though it …

[引用][C] Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity

GY KU, A CHOPRA, G DE LIMA LOPES - Lung cancer, 2010 - pascal-francis.inist.fr
Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced
hepatotoxicity CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …